# VYKAT XR
> **NDA216665** · New Drug Application · Sponsor: SOLENO THERAP · Approved 2025-03-26
## Drug
- **FDA Application Number:** NDA216665
- **Application type:** New Drug Application
- **Brand name:** VYKAT XR
- **Generic name:** DIAZOXIDE CHOLINE
- **Active ingredients:** DIAZOXIDE CHOLINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SOLENO THERAP
- **Manufacturer:** Soleno Therapeutics, Inc.
- **First approval:** 2025-03-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216665)
---
*AI Analytics · CC0 1.0*